Marketing-authorisation holder · United Kingdom

Macleods Pharmaceuticals Limited

United Kingdom48 medicines3 countries

48 medicines in 3 countries, as authorisation holder and manufacturer.

Its medicines

Group structure

Part of

MacleodsPharmaceutical group

Other companies in the group

Spain1

Macleods Pharma Espana S.L.U.

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

1–25 of 48

Medicine	Substance	Country	Status	Authorised
CLOBETASOL PROPIONATE0.05% · Solution	Clobetasol	United States	Marketed	1995
DARIFENACIN15mg base \| 7.5mg base · Tablet, extended release	Darifenacin	United States	Marketed	2017
DIMETHYL FUMARATE120mg \| 240mg · Capsule, delayed release	Dimethyl	United States	Marketed	2018
DONEPEZIL HYDROCHLORIDE10mg \| 23mg \| 5mg · Tablet	Donepezil	United States	Marketed	2007
LEVOTHYROXINE SODIUM0.025MG \| 0.025MG See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium \| 0.050MG \| 0.05MG \| 0.05MG See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium \| 0.075MG \| 0.075MG See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium \| 0.088MG \| 0.088MG See current Annual Edition, 1.8 Descriptio · Tablet	Levothyroxine	United States	Marketed	2002
NYSTATIN100,000 units/gm · Ointment	Nystatin	United States	Marketed	1982
PIOGLITAZONE HYDROCHLORIDE15mg base \| 30mg base \| 45mg base · Tablet	Pioglitazone	United States	Marketed	2012
RIFAPENTINE TABLETS150 mg · Tablet	Rifapentine	Canada	Authorised
RIZATRIPTAN BENZOATE10mg base \| 5mg base · Tablet, orally disintegrating	Rizatriptan	United States	Marketed	2012
SEVELAMER CARBONATE800mg · Tablet	Sevelamer	United States	Marketed	2017
TELMISARTAN AND HYDROCHLOROTHIAZIDE12.5mg; 40mg \| 12.5mg; 80mg \| 25mg; 80mg · Tablet	Hydrochlorothiazide, Telmisartan	United States	Marketed	2014
TENOFOVIR DISOPROXIL FUMARATE150mg \| 200mg \| 250mg \| 300mg · Tablet	Tenofovir disoproxil	United States	Marketed	2015
TOLTERODINE TARTRATE1mg \| 2mg · Tablet	Tolterodine	United States	Marketed	2011
Carbimazole Macleods	Carbimazole	Saudi Arabia	Authorised
DEFRA 120MG DELAYED RELEASE CAPSULES	Dimethyl	Saudi Arabia	Authorised
DEFRA 240MG DELAYED RELEASE CAPSULES	Dimethyl	Saudi Arabia	Authorised
DIOZAD	Valsartan, Hydrochlorothiazide	Saudi Arabia	Authorised
DIOZADVALSARTAN	Valsartan, Hydrochlorothiazide	Saudi Arabia	Authorised
ETHIONAMIDE 250 MG FCT	Etionamida	Saudi Arabia	Authorised
Fumadi	Dimethyl	Saudi Arabia	Authorised
ISONIAZID 100MG TABLET	Isoniazid	Saudi Arabia	Authorised
ISONIAZID 300MG TABLET	Isoniazid	Saudi Arabia	Authorised
Lanacet	Cinacalcet	Saudi Arabia	Authorised
LEUKAIR	Montelukast	Saudi Arabia	Authorised
Lotac	Ticagrelor	Saudi Arabia	Authorised

Sources and licences

Country	Medicines	Current	Past	Companies
United States	25	12	13	Companies All medicines
Saudi Arabia	22	22	0	Companies All medicines
Canada	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

All 8 sources

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.

Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only

Report an error or request removalCorrections from the company itself are welcome.

Macleods Pharmaceuticals Limited

Group structure

Part of

Other companies in the group

Spain1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

United Kingdom: more companies

Group structure

Part of

Other companies in the group

🇪🇸Spain1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Spain1